Precise Biometrics AB (publ) Logo

Precise Biometrics AB (publ)

PREC.ST

(1.5)
Stock Price

3,73 SEK

-26.82% ROA

-13.43% ROE

-14.81x PER

Market Cap.

309.517.200,00 SEK

14.51% DER

0% Yield

-26.39% NPM

Precise Biometrics AB (publ) Stock Analysis

Precise Biometrics AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Precise Biometrics AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.42x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (14%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (5), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

5 ROE

Negative ROE (-19.89%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-30.3%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Precise Biometrics AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Precise Biometrics AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Precise Biometrics AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Precise Biometrics AB (publ) Revenue
Year Revenue Growth
2001 14.097.000
2002 22.469.000 37.26%
2003 13.645.000 -64.67%
2004 30.007.000 54.53%
2005 45.053.000 33.4%
2006 47.733.000 5.61%
2007 24.815.000 -92.36%
2008 45.868.000 45.9%
2009 68.655.000 33.19%
2010 44.944.000 -52.76%
2011 21.615.000 -107.93%
2012 28.281.000 23.57%
2013 34.944.000 19.07%
2014 31.387.000 -11.33%
2015 56.337.000 44.29%
2016 97.223.000 42.05%
2017 61.039.000 -59.28%
2018 67.645.000 9.77%
2019 91.927.000 26.41%
2020 92.349.000 0.46%
2021 83.319.000 -10.84%
2022 91.020.000 8.46%
2023 70.880.000 -28.41%
2023 75.069.000 5.58%
2024 82.328.000 8.82%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Precise Biometrics AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2001 29.012.000
2002 28.394.000 -2.18%
2003 23.195.000 -22.41%
2004 20.451.000 -13.42%
2005 17.617.000 -16.09%
2006 18.304.000 3.75%
2007 13.762.000 -33%
2008 14.444.000 4.72%
2009 12.092.000 -19.45%
2010 12.526.000 3.46%
2011 15.157.000 17.36%
2012 18.239.000 16.9%
2013 21.307.000 14.4%
2014 28.984.000 26.49%
2015 31.275.000 7.33%
2016 26.152.000 -19.59%
2017 25.276.000 -3.47%
2018 33.519.000 24.59%
2019 35.794.000 6.36%
2020 35.941.000 0.41%
2021 28.161.000 -27.63%
2022 34.905.000 19.32%
2023 32.156.000 -8.55%
2023 32.104.999 -0.16%
2024 28.344.000 -13.27%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Precise Biometrics AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 7.450.000
2002 8.415.000 11.47%
2003 5.801.000 -45.06%
2004 6.425.000 9.71%
2005 -22.652.000 128.36%
2006 -40.814.000 44.5%
2007 9.608.000 524.79%
2008 11.096.000 13.41%
2009 12.554.000 11.61%
2010 10.012.000 -25.39%
2011 11.489.000 12.86%
2012 13.909.000 17.4%
2013 14.706.000 5.42%
2014 14.343.000 -2.53%
2015 13.587.000 -5.56%
2016 15.192.000 10.56%
2017 14.105.000 -7.71%
2018 15.508.000 9.05%
2019 14.811.000 -4.71%
2020 15.181.000 2.44%
2021 18.018.000 15.75%
2022 17.613.000 -2.3%
2023 14.168.000 -24.32%
2023 14.150.000 -0.13%
2024 14.976.000 5.52%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Precise Biometrics AB (publ) EBITDA
Year EBITDA Growth
2001 -70.489.000
2002 -74.368.000 5.22%
2003 -54.406.000 -36.69%
2004 -38.614.000 -40.9%
2005 -31.992.000 -20.7%
2006 -81.747.000 60.86%
2007 -35.298.000 -131.59%
2008 -51.096.000 30.92%
2009 -20.218.000 -152.73%
2010 -14.460.000 -39.82%
2011 -30.915.000 53.23%
2012 -40.059.000 22.83%
2013 -34.849.000 -14.95%
2014 -31.271.000 -11.44%
2015 457.000 6942.67%
2016 24.836.000 98.16%
2017 -9.923.000 350.29%
2018 -10.342.000 4.05%
2019 434.000 2482.95%
2020 -6.309.000 106.88%
2021 -13.126.000 51.94%
2022 -20.056.000 34.55%
2023 -29.128.000 31.15%
2023 -1.088.000 -2577.21%
2024 896.000 221.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Precise Biometrics AB (publ) Gross Profit
Year Gross Profit Growth
2001 3.687.000
2002 3.135.000 -17.61%
2003 3.823.000 18%
2004 12.953.000 70.49%
2005 16.146.000 19.78%
2006 18.919.000 14.66%
2007 8.887.000 -112.88%
2008 22.544.000 60.58%
2009 35.792.000 37.01%
2010 27.519.000 -30.06%
2011 12.067.000 -128.05%
2012 15.786.000 23.56%
2013 18.968.000 16.78%
2014 17.179.000 -10.41%
2015 47.922.000 64.15%
2016 76.650.000 37.48%
2017 56.948.000 -34.6%
2018 57.645.000 1.21%
2019 79.457.000 27.45%
2020 77.768.000 -2.17%
2021 63.543.000 -22.39%
2022 65.038.000 2.3%
2023 45.396.000 -43.27%
2023 47.823.000 5.07%
2024 58.804.000 18.67%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Precise Biometrics AB (publ) Net Profit
Year Net Profit Growth
2001 -68.113.000
2002 -73.611.000 7.47%
2003 -54.118.000 -36.02%
2004 -38.072.000 -42.15%
2005 -41.034.000 7.22%
2006 -90.875.000 54.85%
2007 -35.289.000 -157.52%
2008 -54.180.000 34.87%
2009 -21.772.000 -148.85%
2010 -14.648.000 -48.63%
2011 -33.216.000 55.9%
2012 -46.952.000 29.26%
2013 -43.272.000 -8.5%
2014 -44.045.000 1.76%
2015 -9.469.000 -365.15%
2016 31.193.000 130.36%
2017 -17.431.000 278.95%
2018 -20.454.000 14.78%
2019 1.021.000 2103.33%
2020 -12.164.000 108.39%
2021 -13.446.000 9.53%
2022 -22.230.000 39.51%
2023 -30.788.000 27.8%
2023 -26.403.000 -16.61%
2024 -22.260.000 -18.61%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Precise Biometrics AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 -105
2002 -101 -4%
2003 -13 -733.33%
2004 -4 -300%
2005 -3 0%
2006 -7 50%
2007 -2 -500%
2008 -3 50%
2009 -1 -100%
2010 -1 0%
2011 -1 100%
2012 -2 0%
2013 -1 0%
2014 -1 0%
2015 0 0%
2016 1 0%
2017 0 0%
2018 -1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Precise Biometrics AB (publ) Free Cashflow
Year Free Cashflow Growth
2001 -90.596.000
2002 -65.621.000 -38.06%
2003 -45.724.000 -43.52%
2004 -30.161.000 -51.6%
2005 -39.817.000 24.25%
2006 -41.594.000 4.27%
2007 -36.847.000 -12.88%
2008 -20.067.000 -83.62%
2009 -21.253.000 5.58%
2010 -10.382.000 -104.71%
2011 -44.925.000 76.89%
2012 -57.746.000 22.2%
2013 -45.961.000 -25.64%
2014 -42.366.000 -8.49%
2015 -7.463.000 -467.68%
2016 32.391.000 123.04%
2017 13.326.000 -143.07%
2018 -37.441.000 135.59%
2019 -6.320.000 -492.42%
2020 3.999.000 258.04%
2021 -21.075.000 118.98%
2022 -17.809.000 -18.34%
2023 -10.516.000 -69.35%
2023 -26.076.000 59.67%
2024 1.181.000 2307.96%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Precise Biometrics AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2001 -67.107.000
2002 -58.744.000 -14.24%
2003 -43.234.000 -35.87%
2004 -28.127.000 -53.71%
2005 -34.523.000 18.53%
2006 -34.091.000 -1.27%
2007 -36.773.000 7.29%
2008 -19.833.000 -85.41%
2009 -21.207.000 6.48%
2010 -10.138.000 -109.18%
2011 -36.247.000 72.03%
2012 -48.603.000 25.42%
2013 -34.212.000 -42.06%
2014 -34.496.000 0.82%
2015 -4.459.000 -673.63%
2016 37.658.000 111.84%
2017 22.788.000 -65.25%
2018 -26.055.000 187.46%
2019 -477.000 -5362.26%
2020 21.792.000 102.19%
2021 -1.493.000 1559.61%
2022 3.931.000 137.98%
2023 -7.542.000 152.12%
2023 -10.760.000 29.91%
2024 3.855.000 379.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Precise Biometrics AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2001 23.489.000
2002 6.877.000 -241.56%
2003 2.490.000 -176.18%
2004 2.034.000 -22.42%
2005 5.294.000 61.58%
2006 7.503.000 29.44%
2007 74.000 -10039.19%
2008 234.000 68.38%
2009 46.000 -408.7%
2010 244.000 81.15%
2011 8.678.000 97.19%
2012 9.143.000 5.09%
2013 11.749.000 22.18%
2014 7.870.000 -49.29%
2015 3.004.000 -161.98%
2016 5.267.000 42.97%
2017 9.462.000 44.34%
2018 11.386.000 16.9%
2019 5.843.000 -94.87%
2020 17.793.000 67.16%
2021 19.582.000 9.14%
2022 21.740.000 9.93%
2023 2.974.000 -631%
2023 15.316.000 80.58%
2024 2.674.000 -472.77%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Precise Biometrics AB (publ) Equity
Year Equity Growth
2001 82.616.000
2002 67.245.000 -22.86%
2003 50.072.000 -34.3%
2004 67.769.000 26.11%
2005 104.404.000 35.09%
2006 95.016.000 -9.88%
2007 71.201.000 -33.45%
2008 16.004.000 -344.9%
2009 45.408.000 64.76%
2010 31.244.000 -45.33%
2011 46.988.000 33.51%
2012 48.195.000 2.5%
2013 134.547.000 64.18%
2014 91.983.000 -46.27%
2015 83.059.000 -10.74%
2016 163.011.000 49.05%
2017 145.805.000 -11.8%
2018 125.481.000 -16.2%
2019 126.467.000 0.78%
2020 114.044.000 -10.89%
2021 128.053.000 10.94%
2022 146.302.000 12.47%
2023 164.577.000 11.1%
2023 159.319.000 -3.3%
2024 150.927.000 -5.56%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Precise Biometrics AB (publ) Assets
Year Assets Growth
2001 99.172.000
2002 87.185.000 -13.75%
2003 58.376.000 -49.35%
2004 80.472.000 27.46%
2005 125.705.000 35.98%
2006 126.679.000 0.77%
2007 86.151.000 -47.04%
2008 34.012.000 -153.3%
2009 73.093.000 53.47%
2010 48.091.000 -51.99%
2011 64.405.000 25.33%
2012 85.651.000 24.81%
2013 152.924.000 43.99%
2014 106.200.000 -44%
2015 98.949.000 -7.33%
2016 196.096.000 49.54%
2017 189.618.000 -3.42%
2018 158.787.000 -19.42%
2019 158.473.000 -0.2%
2020 152.953.000 -3.61%
2021 241.052.000 36.55%
2022 213.222.000 -13.05%
2023 223.360.000 4.54%
2023 212.665.000 -5.03%
2024 207.636.000 -2.42%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Precise Biometrics AB (publ) Liabilities
Year Liabilities Growth
2001 16.556.000
2002 19.940.000 16.97%
2003 8.304.000 -140.13%
2004 12.703.000 34.63%
2005 21.301.000 40.36%
2006 31.663.000 32.73%
2007 14.950.000 -111.79%
2008 18.008.000 16.98%
2009 27.685.000 34.95%
2010 16.847.000 -64.33%
2011 17.417.000 3.27%
2012 37.456.000 53.5%
2013 18.377.000 -103.82%
2014 14.217.000 -29.26%
2015 15.890.000 10.53%
2016 33.085.000 51.97%
2017 43.813.000 24.49%
2018 33.306.000 -31.55%
2019 32.006.000 -4.06%
2020 38.909.000 17.74%
2021 112.999.000 65.57%
2022 66.920.000 -68.86%
2023 58.783.000 -13.84%
2023 53.346.000 -10.19%
2024 56.709.000 5.93%

Precise Biometrics AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.02
Net Income per Share
-0.27
Price to Earning Ratio
-14.81x
Price To Sales Ratio
3.85x
POCF Ratio
-33.57
PFCF Ratio
-14.51
Price to Book Ratio
2.08
EV to Sales
3.61
EV Over EBITDA
-86.01
EV to Operating CashFlow
-30.99
EV to FreeCashFlow
-13.58
Earnings Yield
-0.07
FreeCashFlow Yield
-0.07
Market Cap
0,31 Bil.
Enterprise Value
0,29 Bil.
Graham Number
3.42
Graham NetNet
0.04

Income Statement Metrics

Net Income per Share
-0.27
Income Quality
0.45
ROE
-0.13
Return On Assets
-0.1
Return On Capital Employed
-0.12
Net Income per EBT
0.98
EBT Per Ebit
1.02
Ebit per Revenue
-0.26
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
0.18
Research & Developement to Revenue
0.37
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.68
Operating Profit Margin
-0.26
Pretax Profit Margin
-0.27
Net Profit Margin
-0.26

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.12
Free CashFlow per Share
-0.27
Capex to Operating CashFlow
-1.28
Capex to Revenue
0.15
Capex to Depreciation
0.5
Return on Invested Capital
-0.12
Return on Tangible Assets
-0.27
Days Sales Outstanding
106.71
Days Payables Outstanding
0
Days of Inventory on Hand
4.2
Receivables Turnover
3.42
Payables Turnover
0
Inventory Turnover
87
Capex per Share
0.15

Balance Sheet

Cash per Share
0,53
Book Value per Share
1,92
Tangible Book Value per Share
0.28
Shareholders Equity per Share
1.92
Interest Debt per Share
0.29
Debt to Equity
0.15
Debt to Assets
0.11
Net Debt to EBITDA
5.89
Current Ratio
1.97
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
172831000
Working Capital
0,03 Bil.
Intangibles to Total Assets
0.62
Average Receivables
0,03 Bil.
Average Payables
0,00 Bil.
Average Inventory
291500
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Precise Biometrics AB (publ) Dividends
Year Dividends Growth

Precise Biometrics AB (publ) Profile

About Precise Biometrics AB (publ)

Precise Biometrics AB (publ) offers identification software for the secure authentication of people's identity in Europe, Asia, and the United States. It provides Precise YOUNiQ that verifies digital identity; Precise BioMatch Card, a fingerprint algorithm solution for identity authentication in smart cards; Precise BioMatch Mobile, a fingerprint algorithm solution for identity authentication in smartphones and tablets; and Precise BioLive, a fingerprint software that identifies a fake fingerprint. The company offers its products to sensor manufacturers, security companies, and system integrators, as well as finance, betting, healthcare, and transport sectors. Precise Biometrics AB (publ) was incorporated in 1997 and is headquartered in Lund, Sweden.

CEO
Mr. Joakim Nydemark
Employee
32
Address
ScheelevAegen 27
Lund, 223 63

Precise Biometrics AB (publ) Executives & BODs

Precise Biometrics AB (publ) Executives & BODs
# Name Age
1 Mr. Joakim Nydemark
Chief Executive Officer
70
2 Ms. Maria Wester
Chief Financial Officer
70
3 Mr. Henrik Winberg
CCO - Biometric Technologies
70
4 Mr. Sarandis Kalogeropoulos
Chief Commercial Officer of Digital Identity
70
5 Mr. Fredrik Andre
Chief Marketing Officer
70
6 Ms. Ann-sofi Höijenstam
Director of Investors Relations & Communications
70

Precise Biometrics AB (publ) Competitors